when will insurance cover semaglutide coverage and type of employment shape inequities in access to Does insurance cover Wegovy? |

GLP-1 receptor agonists (GLP-1RAs) show clinical promise, and the prevailing hypothesis is that their benefits are primarily driven by weight loss and the downstream benefits of improved functional status

Rapid improvement in glucose control has been associated with a temporary worsening of diabetic retinopathy, but other mechanisms cannot be excluded

Helping manage common medication side effects

Get tips from a real physician to improve the medical clearance process.

Our Thermogenic is designed to accelerate fat loss and support weight management by increasing metabolic rate and energy expenditure

June 2, 2026 Results of an American College of Radiology-managed retrospective study involving 110,000 womenpresented at the 2026 ASCO Annual Meeting, shows that those who took GLP-1 medications were up to 35% less likely to develop breast cancer than those who did not take GLP-1 drugs. ACR urges funding of a large prospective study to clarify impact of these drugs on cancer incidence and prevention.